--- title: "N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study" id: "bmj-open-6-n-terminal-probnp-adds-prognostic-value-to-high-sensitivity-cardiac-troponin-i-in-elective-thoracic-surgery-an-observational-cohort-study" canonical_url: "https://medichelpline.com/clinical-feed/bmj-open-6-n-terminal-probnp-adds-prognostic-value-to-high-sensitivity-cardiac-troponin-i-in-elective-thoracic-surgery-an-observational-cohort-study" content_type: "clinical_feed_article" specialty: "Research Highlights" source_name: "BMJ Open" source_url: "http://bmjopen.bmj.com/cgi/content/short/16/4/e108073?rss=1" published_at: "2026-04-17T13:04:38.000Z" evidence_level: "Journal Feed" license: "CC-BY-NC-4.0 / Informational Use" --- # N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study ## Provenance & Clinical Metadata - **Canonical URL:** https://medichelpline.com/clinical-feed/bmj-open-6-n-terminal-probnp-adds-prognostic-value-to-high-sensitivity-cardiac-troponin-i-in-elective-thoracic-surgery-an-observational-cohort-study - **Specialty:** [Research Highlights](https://medichelpline.com/clinical-feed/research-highlights.md) - **Primary Source:** BMJ Open - **Source URL:** [Original Journal Publication](http://bmjopen.bmj.com/cgi/content/short/16/4/e108073?rss=1) - **Published At:** 2026-04-17T13:04:38.000Z - **Evidence Rating:** Journal Feed ## Executive GIST (TL;DR) Background Perioperative myocardial injury (PMI) is a common complication following non-cardiac, particularly thoracic, surgery and is associated with increased cardiovascular risk. Although guidelines recommend cardiac biomarker monitoring to detect PMI, its implementation in routine clinical practice remains limited. Objective To evaluate the combined use of high-sensitivity cardiac troponin I (hs-cTnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in predicting major adverse cardiovascular events (MACE) following elective thoracic surgery, and to determine whether NT-proBNP provides incremental prognostic value beyond hs-cTnI alone. Design Multicentre observational cohort study. Setting Conducted between February 2021 and November 2023 in three Spanish tertiary hospitals. Participants Patients aged ≥45 years scheduled for elective thoracic surgery involving lung resection (pneumonectomy, lobectomy, bilobectomy or segmentectomy) under general anaesthesia. Exclusion criteria included urgent or non-thoracic surgery, active infection or sepsis and a history of severe heart failure (ejection fraction Main outcome measures Combined measurement of hs-cTnI and NT-proBNP at baseline (preoperatively) and at 24 and 48 hours postoperatively. PMI was defined as hs-cTnI ≥45 ng/L at 24 and/or 48 hours or a ≥20% increase from baseline in patients with elevated preoperative concentrations. Results Among 475 patients, PMI occurred in 11.8%. PMI had higher rates of prior stroke (12.5% vs 2.9%; p=0.004), smoking history (85.7% vs 64.0%; p=0.001) and severe renal dysfunction (7.1% vs 0.7%; p=0.001), with similar Revised Cardiac Risk Index distribution. Patients with PMI also had greater postoperative elevations of hs-cTnI and NT-proBNP (p Conclusions Combined hs-cTnI and NT-proBNP assessment improves perioperative cardiovascular risk stratification beyond ischaemia. Trial registration number NCT04749212 ## Clinical Analysis & Structured Key Points Background Perioperative myocardial injury (PMI) is a common complication following non-cardiac, particularly thoracic, surgery and is associated with increased cardiovascular risk. Although guidelines recommend cardiac biomarker monitoring to detect PMI, its implementation in routine clinical practice remains limited. Objective To evaluate the combined use of high-sensitivity cardiac troponin I (hs-cTnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in predicting major adverse cardiovascular events (MACE) following elective thoracic surgery, and to determine whether NT-proBNP provides incremental prognostic value beyond hs-cTnI alone. Design Multicentre observational cohort study. Setting Conducted between February 2021 and November 2023 in three Spanish tertiary hospitals. Participants Patients aged ≥45 years scheduled for elective thoracic surgery involving lung resection (pneumonectomy, lobectomy, bilobectomy or segmentectomy) under general anaesthesia. Exclusion criteria included urgent or non-thoracic surgery, active infection or sepsis and a history of severe heart failure (ejection fraction Main outcome measures Combined measurement of hs-cTnI and NT-proBNP at baseline (preoperatively) and at 24 and 48 hours postoperatively. PMI was defined as hs-cTnI ≥45 ng/L at 24 and/or 48 hours or a ≥20% increase from baseline in patients with elevated preoperative concentrations. Results Among 475 patients, PMI occurred in 11.8%. PMI had higher rates of prior stroke (12.5% vs 2.9%; p=0.004), smoking history (85.7% vs 64.0%; p=0.001) and severe renal dysfunction (7.1% vs 0.7%; p=0.001), with similar Revised Cardiac Risk Index distribution. Patients with PMI also had greater postoperative elevations of hs-cTnI and NT-proBNP (p Conclusions Combined hs-cTnI and NT-proBNP assessment improves perioperative cardiovascular risk stratification beyond ischaemia. Trial registration number NCT04749212 ## Related Clinical Research - [MEWS in Ethiopia: Predicting and Reducing Severe Maternal Outcomes](https://medichelpline.com/clinical-feed/plos-one-17-maternal-early-warning-system-mews-model-for-predicting-and-reducing-severe.md) - [Multimodal extraction of heart disease risk factors from free-text and structured records using Li](https://medichelpline.com/clinical-feed/plos-one-0-leveraging-free-text-clinical-records-for-heart-disease-classification-through.md) - [Neural-Immune-Cardiovascular Axis: Mechanisms and Therapeutic Targets in Cardiovascular Disease](https://medichelpline.com/clinical-feed/frontiers-in-immunology-13-neural-immune-cardiovascular-axis-from-mechanistic-crosstalk-to-therapeutic.md) - [Post-stroke acute heart failure in patients with large vessel occlusion undergoing endovascular treatment: A pooled analysis of individual patient data from multicenter studies with mediation analysis](https://medichelpline.com/clinical-feed/plos-medicine-1-post-stroke-acute-heart-failure-in-patients-with-large-vessel-occlusion.md) - [Cardiovascular and renal outcomes of combined SGLT2 inhibitors and GLP-1 receptor agonists versus monotherapy in patients with type 2 diabetes mellitus: a network meta-analysis [Research]](https://medichelpline.com/clinical-feed/cmaj-0-cardiovascular-and-renal-outcomes-of-combined-sglt2-inhibitors-and-glp-1.md) ## Navigation - [← Back to Research Highlights Feed](https://medichelpline.com/clinical-feed/research-highlights.md) - [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md) ## Medical & Regulatory Disclaimer > [!CAUTION] > MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations. > Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.